TABLE 2.
Sensitivity analysis.
| Omitted study | MD | 95% CI | |
|---|---|---|---|
| Lower | Upper | ||
| Scr (μmol/L) | |||
| Wenping G (2019) | −10.27 | −17.78 | −2.76 |
| Jing L (2020) | −9.83 | −17.07 | −2.60 |
| Xiaohong G (2021) | −8.53 | −17.25 | 0.18 |
| Chenguang D (2021) | −5.08 | −9.41 | −0.75 |
| Ziyu W (2022) | −7.42 | −14.25 | −0.58 |
| Haiwei C (2022) | −7.86 | −14.93 | −0.79 |
| Combined | −8.00 | −14.33 | −1.66 |
| eGFR (mL/min/1.73 m 2 ) | |||
| Gaber AO (2013) | 2.43 | −2.18 | 7.04 |
| Abedini S (2018) | 2.21 | −2.71 | 7.13 |
| Rubik J (2019) | 3.12 | −0.25 | 6.48 |
| Wenping G (2019) | 1.00 | −2.46 | 4.46 |
| Hugo C (2021) | 2.75 | −2.08 | 7.57 |
| Xiaohong G (2021) | 1.35 | −2.89 | 5.58 |
| Combined | 2.21 | −1.62 | 6.03 |
MD, mean difference; CI, confidence interval; Scr, serum creatinine; eGFR, estimated glomerular filtration rate.